Galapagos reported €2.14B in Cash and Equivalent for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
AstraZeneca AZN:LN 7067M 8500M
Biogen BIIB:US $ 1541.8M 200.2M
Genmab GEN:DC DK 8729M 748M
Gilead Sciences GILD:US $ 6837M 1944M
GlaxoSmithKline GSK:LN 3453M 50M
GRIFOLS GRF:SM € 397.86M 16.88M
Hikma Pharmaceutical HIK:LN 2M 321M
Merck MRK:GR € 1523M 302M
Neurocrine Biosciences NBIX:US $ 311.1M 56.9M
Novartis NOVN:VX SF 7211M 2094M
Vertex Pharmaceuticals VRTX:US $ 6275.7M 212.02M
YTE INCY:US $ 1999.02M 201.44M